This Privacy Policy explains Diagonal Therapeutics, Inc.
diagonaltx.com
Actively hiring
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Backers
3
RA Capital Management, Atlas Venture
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
RA Capital Management 
Atlas Venture 
EcoR1 Capital Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Kymera is inventing a new generation of small molecule medicines by tackling the root cause of disease with targeted protein degradation.
Vima Therapeutics is advancing a new era in treatment to help people living with movement disorders regain the freedom to move.
DEVELOPING INHALED THERAPEUTICS IN RESPIRATORY DISEASES. Kinaset is developing KN-002 to treat all patients with severe asthma regardless…
Pioneering RNA-based science to target the root cause of rare genetic neurological diseases VO659: The first clinical candidate directly…
Clinically-validated Superculture® ingredients target the root causes of unmet pet health needs.
COMPANY Now is the time for surgical therapeutics Peptilogics is a clinical stage company advancing its lead engineered peptide, zaloganan…